EMOR Healixa Inc
WatchlistHealixa Inc News
Healixa Inc. and Modern Homestead Industries Join Forces to Revolutionize Global Water Access With the Launch of Healixa's Deposition Water Harvesting Technology
Healixa, a trailblazing innovator in disruptive technologies, is proud to announce a global brand and license partnership with Modern Homestead Industries to offer its groundbreaking Deposition Water
Healixa Inc. Completes Global AquaDuct Deposition Water Harvesting Technology Beta Development Program and Commences Pre-Commercialization Testing Program
Field Trials to Begin Following Comprehensive Product and Independent Third-Party Water Quality Testing ProgramNew York, NY, July 06, 2023 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC: EMOR) ("Healixa" or
Healixa Announces Major Milestone Towards Commercialization Of Its Global AquaDuct Product
Healixa, Inc. (OTC:EMOR) ("Healixa," or the "Company"), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech i
Healixa Inc. Appoints Former Pennsylvania Senator Richard Alloway II as Executive Vice President for Government Relations
Executive Appointment Further Supports the Company's Mission to Support Sustainable Communities and Advance its Global AquaDuct™ Water InitiativesNew York, NY, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Heal
Healixa Expands Advisory Board With Appointment of Accomplished C-Level Executive With History of Accelerating Profitable Growth
New York, NY, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC: EMOR) ("Healixa," or the "Company"), a technology company focusing on building and acquiring innovative and disruptive technologie
Healixa Health Care Signs Initial Revenue Contracts
Manhattan, NY, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa", or the "Company"), a technology company focusing on building and acquiring innovative and disruptive techn
Healixa Inc Retains Investment Bank Firm Craft Capital Management LLC to Provide Investment Banking and Up-Listing Advisory Services
New York, NY, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC: EMOR) ("Healixa," or the "Company"), a technology company focusing on building and acquiring innovative and disruptive technologie
Healixa Appoints Diane Koontz As President of Healixa Health Care
Healixa, Inc. (OTC: EMOR) Bolsters Its Executive Team with Appointment of Accomplished Health Care ExecutiveManhattan, NY, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa"
Healixa, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
ORLANDO, FL / ACCESSWIRE / August 26, 2022 / RedChip Companies will air a new interview with Healixa, Inc. (OTC Pink:EMOR) ("Healixa," or the "Company"), a technology company focusing on building and
Healixa Strengthens Advisory Board with Appointment of Award-Winning Executive Satyajit Deb
Satyajit recognized for several "world's first" innovations by the marketing and advertising industryNew York, NY, July 28, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa," or the
Healixa announces manufacturing supply deal for Global Aquaduct units
Healixa (OTCPK:EMOR) said Tuesday it secured a manufacturing supply agreement for its Global Aquaduct atmospheric water harvesting units with Allied Manufacturing Industry. The deal allows EMOR to add
Healixa Secures Manufacturing Agreement for its Global AquaDuct™ Atmospheric Water Harvesting Units with Industry Leader Allied Manufacturing Industry LLC
Production Ramp Up to Support $75 Million of Global Aquaduct™ Pre-Sales and Rapidly Growing PipelineNew York, NY, April 12, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa", or the
Healixa Secures An Additional $22,500,000 In Order Indications For Its Global AquaDuct™ Units in South America
• Healixa, Inc. has received order indication from WATERisLIFE for 1,500 units of its Global AquaDuct™ representing pre-sales indications of $22,500,000 adding to the already $15,000,000 in IOI's alre
Healixa Secures $15,000,000 In Order Indications For Its Global AquaDuct™ Units In Central America
•Healixa, Inc. has received order indication from WATERisLIFE for 1,000 units of its Global AquaDuct™ representing pre-sales indications of $15,000,000 •These order indications are specific to project
Healixa Enters Definitive Solar Components Supply Agreement with Solar Integrated Roofing Corp. for its Global Aquaduct ™ Atmospheric Water Harvesting Units
• Healixa, Inc. to Source Global Aquaduct Component Parts from Solar Integrated Roofing Corp. • Healixa and SIRC shall exchange shares giving each of their respective shareholders 100 shares of the ot
Healixa Begins Accepting Indications of Interest for its Global Aquaduct™ Atmospheric Water Harvesting Units
Healixa, Inc. (OTC: EMOR) Begins Its Pre-Order Process For Global Aquaduct™Manhattan, NY, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa", or the "Company"), a technology
Healixa Appoints Richard Alloway II to its Advisory Board
Manhattan, NY, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC Pink: EMOR) ("Healixa", or the "Company"), a technology company focusing on building and acquiring innovative and disruptive techn
Healixa Appoints Diane Koontz to its Advisory Board
Manhattan, NY, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC:EMOR) ("Healixa", or the "Company"), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech indu
Healixa, Inc. (OTC: EMOR) Appoints Accomplished Independent Director to its Board in Step Towards National Securities Exchange Listing Requirements
Manhattan, NY, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC:EMOR) ("Healixa", or the "Company"), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech ind
Healixa Inc. to Deliver a Live Webinar Presentation via the Skyline Signature Series (TM) on Wednesday, December 8th, 2021
The Company invites individual and institutional investors, as well as advisors and analysts, to attend this real-time, interactive presentation at the Signature Series (TM)Manhattan, NY, Dec. 02, 20